Press Release: UK Leading British Medical Cannabis and CBD Company, Cannaray, Announces First UK Medical Cannabis Prescription 

Press Release: UK Leading British Medical Cannabis and CBD Company, Cannaray, Announces First UK Medical Cannabis Prescription 

Following a £7.8 million Series A funding round in 2019, Cannaray has announced the fulfilment of its first UK patient prescription as the company continues to grow, becoming one of UK’s largest Medical Cannabis and CBD company.  Cannaray today announces the fulfilment of its first Medical Cannabis prescription in the UK. The fulfilment, which has been prescribed to Jorja Emerson, a three-year-old British girl who suffers from severe epilepsy, demonstrates a real progression in the quest to allow patients to access pioneering treatments of Medical Cannabis. In collaboration with one of the world’s largest Cannabis companies Aphria Inc, Cannaray was able to fulfil this prescription. Aphria has novel cannabis formulations and delivery systems that are to European medical standards which are currently not available from other sources for UK patients. With a Series A funding round securing the backing of £7.8 million, Cannaray is pleased to be able to mark this significant milestone with Jorja’s prescription, cementing its position as one of Europe’s leading Medical Cannabis and CBD company. Cannaray CEO, Scott Maguire commented: “Working with the medical community to provide specialist support and access to cannabis-based drugs for patients in dire need of this treatment is fundamental to our strategy. We…

Excerpt only …
READ MORE BELOW
Source : CANNANNEW REPORT
Link to original : Press Release: UK Leading British Medical Cannabis and CBD Company, Cannaray, Announces First UK Medical Cannabis Prescription 
reposted by Cannabis News World

Advertisements

This site uses Akismet to reduce spam. Learn how your comment data is processed.